First-of-its-kind COVID-19 antibody treatment: FDA authorization requested | FDACDC
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us
Home \ News \ First-of-its-kind COVID-19 antibody treatment: FDA authorization requested
More  
First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

NOW PLAYING
First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

CDC Statement on ACIP Booster Recommendations

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Top COVID-19 doctors and scientists privately asked the Biden administration to scrap its booster-shot plan, report says

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

FDA review finds Moderna’s booster dose of its coronavirus vaccine strengthens disease-fighting response

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Myths and Facts about COVID-19 Vaccines

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

TENSE DECISION MAKING BETWEEN CDC AND FDA

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

FDACDC.com

Views
0
0
0
0 0
   
Share this with your friends via:     
   

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

TVNET3 November 2, 2021 4:02 pm

It could be the first long-acting antibody combination to receive an emergency authorization in the U.S. for COVID-19 prevention.

Category: News
About The Author
TVNET3 -
Previous

LIVE: FDA advisory panel to vote on J&J Covid booster shots — 10/15/2021

Next

CDC Statement on ACIP Booster Recommendations

Related Videos

FDACDC Phase2

Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry

FDA: Vaccine benefits outweigh risks for young kids

FDA: Vaccine benefits outweigh risks for young kids

FDA panel recommends Pfizer vaccine for kids ages 5-11

FDA panel recommends Pfizer vaccine for kids ages 5-11

FDA Panel Backs Pfizer COVID-19 Booster Shots For Adults 65 And Older

FDA Panel Backs Pfizer COVID-19 Booster Shots For Adults 65 And Older

Vaccines and Related Biological Products Advisory Committee – 9/17/2021

Vaccines and Related Biological Products Advisory Committee – 9/17/2021

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA


[ App Programmed TeleVision Engine ]  was developed by WRLD1 / TVNET as a scalable Mobile Netcast Architecture enabling Geocentric Networks across the 8 regions of the world.

Copyright 2021 WorldNetCast /TVNET

Web Solutions by Wirefreesoft | Google Partner

Visit Our Other Networks

Geo Regions | Global Focused News | http://georegions.com/

FDACDC - FDA CDC News
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us
  • Close
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us

Report Video

Please specify an ID for the Contact Form in Theme Options > Single Post/Video > Video Report Form